Skip to main content
FinSpry Logo
FinSpry
CRDF logo
CRDF
(NASDAQ)
Cardiff Oncology, Inc.
$1.58-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Cardiff Oncology (CRDF) Stock Price & Financial Analysis

Cardiff Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.55 - $1.60
52-Week High$4.56
52-Week Low$1.48
Open$1.60
Volume528.46K
Average Volume (3M)528.46K
Market Cap105.61M
Shares Outstanding66.84M
Price to Sales (P/S)181.47
Price to Book (P/B)2.37
EV/EBITDA-1.92
Revenue (TTM)593.00K
Net Income (TTM)-45.85M
Free Cash Flow (TTM)-37.97M
EPS (TTM)$-0.69
Profit Margin-7732.21%
Operating Margin-8256.32%
Return on Equity (ROE)-101.02%
Debt to Equity0.02
50-Day MA$1.84
200-Day MA$2.42
52-Week Change-47.39%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cardiff Oncology

What is the current stock price for CRDF?

As of the latest trading session, CRDF stock trades at $1.58. The 52-week range is $1.48–$4.56, with a day range of $1.54–$1.60.

What is the P/E ratio for CRDF?

The P/E ratio (Price-to-Earnings) for CRDF is shown in the Key Statistics section. This valuation metric helps compare Cardiff Oncology, Inc. to industry peers.

Does CRDF pay dividends?

Cardiff Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CRDF?

Based on 3 analysts, the consensus for CRDF is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CRDF?

Cardiff Oncology's market capitalization is $105.6M, classifying it as a micro-cap company. Cardiff Oncology operates in the Healthcare sector within the Biotechnology industry.